Therapeutic Solutions International Inc (TSOI)

[OCMillionaire]

HUGE NEW NEWS OUT THIS AM*****

https://ih.advfn.com/stock-market/USOTC/therapeutic-solutions-pk-TSOI/stock-news/82657747/therapeutic-solutions-international-reports-reduct

...
today the filing of a new patent covering suppression of the indolamine 2,3 deoxygenase (IDO) pathway by QuadraMune™ administration.
activity, as quantified using the Morris Water Maze test.

Administration of QuadraMune™ significantly inhibited inflammation associated with memory impairment, as well as reduced levels of kynurenine. Elevation of kynurenine is associated with activation of indolamine 2,3 deoxygenase, an enzyme associated with inflammation and depression

"The IDO enzymatic pathway is not only extremely interesting from a medical perspective, but companies working on manipulating this pathway have previously entered Big Pharma deals with potential values in excess of $1 billion [3]. In contrast to other programs that utilize synthetic approaches, QuadraMune™, which is comprised of natural ingredients and is available as a nutraceutical, may possess numerous advantages for accelerated commercialization.